No abstract available
MeSH terms
-
Cost-Benefit Analysis
-
DNA, Viral / analysis
-
Graft Survival
-
Hepatitis B / complications
-
Hepatitis B / prevention & control
-
Hepatitis B / surgery*
-
Hepatitis B e Antigens / immunology
-
Hepatitis B virus / genetics
-
Hepatitis B virus / immunology
-
Humans
-
Immunization, Passive / economics
-
Immunization, Passive / methods
-
Immunoglobulins / economics
-
Liver Failure / etiology
-
Liver Failure / mortality
-
Liver Failure / surgery
-
Liver Transplantation* / mortality
-
Secondary Prevention
-
Survival Rate
-
United States
Substances
-
DNA, Viral
-
Hepatitis B e Antigens
-
Immunoglobulins
-
hepatitis B hyperimmune globulin